Anacor Pharmaceuticals, Inc. (ANAC)

99.20
NASDAQ
Prev Close 99.20
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.00
Exchange NASDAQ
Div & Yield N.A. (N.A)
Pfizer Buying Anacor in $5.2 Billion Cash Deal

Pfizer Buying Anacor in $5.2 Billion Cash Deal

Pfizer is buying Anacor primarily to gain access to crisaborole, an anti-inflammatory drug currently under FDA review for the treatment of mild-to-moderate atopic dermatitis, commonly referred to as eczema.

Pfizer To Acquire Anacor

Pfizer To Acquire Anacor

Pfizer Inc. (NYSE:PFE) and Anacor Pharmaceuticals, Inc.

Anacor Pharmaceuticals Reports First Quarter 2016 Financial Results

Anacor Pharmaceuticals Reports First Quarter 2016 Financial Results

Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) today announced its financial results for the quarter ended March 31, 2016.

Watch Out: Barbarians At The Gate For Anacor Pharmaceuticals (ANAC)

Watch Out: Barbarians At The Gate For Anacor Pharmaceuticals (ANAC)

Trade-Ideas LLC identified Anacor Pharmaceuticals (ANAC) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate

Anacor Pharmaceuticals To Report First Quarter 2016 Financial Results On May 10, 2016

Anacor Pharmaceuticals To Report First Quarter 2016 Financial Results On May 10, 2016

Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) will release its financial results for the quarter ended March 31, 2016, before the market opens on Tuesday, May 10, 2016.

Will a Third Medivation Suitor Present Itself?

Will a Third Medivation Suitor Present Itself?

Pfizer reportedly made a bid for the cancer drug maker, rivaling Sanofi's $9.3 billion offer, but analysts say another company might be the best fit.

Insider Trading Alert - OZRK, CNBKA And ANAC Traded By Insiders

Insider Trading Alert - OZRK, CNBKA And ANAC Traded By Insiders

Stocks with insider trader activity include OZRK, CNBKA and ANAC

Today's Dead Cat Bounce Stock: Anacor Pharmaceuticals (ANAC)

Today's Dead Cat Bounce Stock: Anacor Pharmaceuticals (ANAC)

Trade-Ideas LLC identified Anacor Pharmaceuticals (ANAC) as a "dead cat bounce" (down big yesterday but up big today) candidate

Anacor Pharmaceuticals To Present At The Deutsche Bank 41st Annual Healthcare Conference

Anacor Pharmaceuticals To Present At The Deutsche Bank 41st Annual Healthcare Conference

Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) announced today that the company's management team will provide a company overview at the Deutsche Bank 41 st Annual Healthcare Conference on Thursday, May 5, 2016 at 2:10 p.

These 5 Stocks Are Poised for Breakouts

These 5 Stocks Are Poised for Breakouts

These stocks look ready to break out and trade higher from current levels.

Allergan Could Buy These Drug Companies Now That the Pfizer Merger Is Scuttled

Allergan Could Buy These Drug Companies Now That the Pfizer Merger Is Scuttled

Now that the Allergan-Pfizer merger is off, Allergan CEO Saunders could start shopping again for biotech and smaller pharma companies to fuel his company's growth.

Anacor Pharmaceuticals (ANAC) Highlighted As Today's Perilous Reversal Stock

Anacor Pharmaceuticals (ANAC) Highlighted As Today's Perilous Reversal Stock

Trade-Ideas LLC identified Anacor Pharmaceuticals (ANAC) as a "perilous reversal" (up big yesterday but down big today) candidate

Biotech M&A Will Flow From the Ashes of Scuttled Pfizer-Allergan Merger

Biotech M&A Will Flow From the Ashes of Scuttled Pfizer-Allergan Merger

Both Allergan and Pfizer could target biotech and drug company acquisitions as a way to fuel future growth.

2 Biotech Companies That Could Profit if Their Skin Treatments Are Successful

2 Biotech Companies That Could Profit if Their Skin Treatments Are Successful

Regeneron's dupilumab treats individuals suffering from severe, chronic eczema, while Anacor's Crisaborole ointment is designed to inhibit the pro-inflammatory proteins that cause the symptoms of atopic dermatitis.

Strong On High Relative Volume: Anacor Pharmaceuticals (ANAC)

Strong On High Relative Volume: Anacor Pharmaceuticals (ANAC)

Trade-Ideas LLC identified Anacor Pharmaceuticals (ANAC) as a strong on high relative volume candidate

Anacor Pharmaceuticals, Inc. Announces Pricing Of Offering Of $250 Million Of 2.00% Convertible Senior Notes Due 2023

Anacor Pharmaceuticals, Inc. Announces Pricing Of Offering Of $250 Million Of 2.00% Convertible Senior Notes Due 2023

Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) announced today the pricing of its offering of $250,000,000 aggregate principal amount of 2.

Anacor Pharmaceuticals, Inc. Announces Proposed Offering Of $250 Million Of Convertible Senior Notes Due 2023

Anacor Pharmaceuticals, Inc. Announces Proposed Offering Of $250 Million Of Convertible Senior Notes Due 2023

Anacor Pharmaceuticals, Inc. (NASDAQ: ANAC) announced today that it intends to offer, subject to market and other considerations, $250,000,000 aggregate principal amount of Convertible Senior Notes due 2023 (the...

Insider Trading Alert - ANAC, SPAR And HLF Traded By Insiders

Insider Trading Alert - ANAC, SPAR And HLF Traded By Insiders

Stocks with insider trader activity include ANAC, SPAR and HLF

Weak On High Volume: Anacor Pharmaceuticals (ANAC)

Weak On High Volume: Anacor Pharmaceuticals (ANAC)

Trade-Ideas LLC identified Anacor Pharmaceuticals (ANAC) as a weak on high relative volume candidate

Stock To Watch: Anacor Pharmaceuticals (ANAC) In Perilous Reversal

Stock To Watch: Anacor Pharmaceuticals (ANAC) In Perilous Reversal

Trade-Ideas LLC identified Anacor Pharmaceuticals (ANAC) as a "perilous reversal" (up big yesterday but down big today) candidate

Insider Trading Alert - FCH, GNBC And ANAC Traded By Insiders

Insider Trading Alert - FCH, GNBC And ANAC Traded By Insiders

Stocks with insider trader activity include FCH, GNBC and ANAC

Anacor Pharmaceuticals To Present At The Cowen And Company 36th Annual Health Care Conference

Anacor Pharmaceuticals To Present At The Cowen And Company 36th Annual Health Care Conference

Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) announced today that the company's management team will present at the Cowen and Company 36 th Annual Health Care Conference on Wednesday, March 9, 2016 at 9:20 a.

Trade-Ideas: Anacor Pharmaceuticals (ANAC) Is Today's Post-Market Leader Stock

Trade-Ideas: Anacor Pharmaceuticals (ANAC) Is Today's Post-Market Leader Stock

Trade-Ideas LLC identified Anacor Pharmaceuticals (ANAC) as a post-market leader candidate

Anacor Pharmaceuticals Reports 2015 Fourth Quarter And Year-End Financial Results

Anacor Pharmaceuticals Reports 2015 Fourth Quarter And Year-End Financial Results

Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) today announced its financial results for the fourth quarter and year ended December 31, 2015.

Anacor Pharmaceuticals Announces Late-Breaking Oral Presentation Of Crisaborole Topical Ointment, 2% Phase 3 Pivotal Data At The 74th Annual Meeting Of The American Academy Of Dermatology

Anacor Pharmaceuticals Announces Late-Breaking Oral Presentation Of Crisaborole Topical Ointment, 2% Phase 3 Pivotal Data At The 74th Annual Meeting Of The American Academy Of Dermatology

Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) announced today that data from its Phase 3 pivotal studies of investigational drug crisaborole topical ointment, 2% will be presented at the 74th Annual Meeting of the American...

Anacor Pharmaceuticals Announces 2015 Fourth Quarter And Year-End Financial Results Conference Call And Webcast

Anacor Pharmaceuticals Announces 2015 Fourth Quarter And Year-End Financial Results Conference Call And Webcast

Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) will release its financial results for the fourth quarter and year ended December 31, 2015, after the market closes on Monday, February 29, 2016.

This Trade Explains the Current Market

This Trade Explains the Current Market

The shifting momentum of asset classes is signaling a changing economic landscape.

Anacor Pharmaceuticals (ANAC) Weak On High Volume

Anacor Pharmaceuticals (ANAC) Weak On High Volume

Trade-Ideas LLC identified Anacor Pharmaceuticals (ANAC) as a weak on high relative volume candidate

Insider Trading Alert - PNK, GME And ANAC Traded By Insiders

Insider Trading Alert - PNK, GME And ANAC Traded By Insiders

Stocks with insider trader activity include PNK, GME and ANAC